Anticoagulation vs Antiplatelet Treatment in Patients with Carotid and Vertebral Artery Dissection: A Study of 370 Patients and Literature Review

被引:56
作者
Daou, Badih
Hammer, Christine
Mouchtouris, Nikolaos
Starke, Robert M.
Koduri, Sravanthi
Yang, Steven
Jabbour, Pascal
Rosenwasser, Robert
Tjoumakaris, Stavropoula
机构
[1] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA
[2] Jefferson Hosp Neurosci, Philadelphia, PA USA
关键词
Antiplatelet; Anticoagulation; Antithrombotic; Carotid; Dissection; Vertebral; TERM-FOLLOW-UP; YOUNG-ADULTS; STROKE; DIAGNOSIS; FEATURES; RISK;
D O I
10.1093/neuros/nyw086
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Dissection of the carotid and vertebral arteries is an important cause of stroke in young patients. OBJECTIVE: The objective of this study is to compare antithrombotic treatments in patients with carotid and vertebral dissections. METHODS: Three hundred seventy patients with carotid and vertebral artery dissections were included. Univariate and multivariate analyses were conducted to analyze the association between treatment and new or recurrent events and clinical outcome. RESULTS: Mean follow-up was 24.3 months. In patients with spontaneous dissection, 55% received antiplatelets, 29.4% anticoagulation, and 12.6% combined treatment. New or recurrent ischemic and hemorrhagic events occurred in 9.6% of patients on antiplatelets, 10.4% on anticoagulation, and 13.3% on combined treatment. For traumatic dissection, 58.3% received antiplatelets, 26.9% anticoagulation, and 10.2% combined treatment. New or recurrent ischemic and hemorrhagic events occurred in 6.9% on antiplatelets, 11.1% on anticoagulation, and 20% on combined treatment. In patients with intracranial dissection, 63.1% were started on antiplatelets, 19.7% on anticoagulation, and 14.5% on combined treatment. Ischemic and hemorrhagic events occurred in 8.5% on antiplatelet treatment, 15.4% on anticoagulation, and 18.2% on combined treatment. In patients with extracranial dissection, 54.4% were on antiplatelets, 28.9% on anticoagulation, and 11.2% on combined treatment. Ischemic and hemorrhagic events occurred in 10.1% on antiplatelet treatment, 9.3% on anticoagulation, and 13.8% on combined treatment. The association between antithrombotic treatment and ischemic/hemorrhagic events and clinical outcome was not significant for all subtypes of dissection. CONCLUSION: The rate of new or recurrent events is similar with antiplatelet and anticoagulation treatment in treating intracranial and extracranial carotid and vertebral artery dissection.
引用
收藏
页码:368 / 378
页数:11
相关论文
共 29 条
[1]   Dissection of cervical arteries:: Long-term follow-up study of 130 consecutive cases [J].
Arauz, Antonio ;
Hoyos, Leticia ;
Espinoza, Carlos ;
Cantu, Carlos ;
Barinagarrementeria, Fernando ;
Roman, Gustavo .
CEREBROVASCULAR DISEASES, 2006, 22 (2-3) :150-154
[2]   Differences in Demographic Characteristics and Risk Factors in Patients With Spontaneous Vertebral Artery Dissections With and Without Ischemic Events [J].
Arnold, Marcel ;
Kurmann, Rebekka ;
Galimanis, Aekaterini ;
Sarikaya, Hakan ;
Stapf, Christian ;
Gralla, Jan ;
Georgiadis, Dimitrios ;
Fischer, Urs ;
Mattle, Heinrich P. ;
Bousser, Marie-Germaine ;
Baumgartner, Ralf W. .
STROKE, 2010, 41 (04) :802-804
[3]   Cervical arterial dissection - Time for a therapeutic trial? [J].
Beletsky, V ;
Nadareishvili, Z ;
Lynch, J ;
Shuaib, A ;
Woolfenden, A ;
Norris, JW .
STROKE, 2003, 34 (12) :2856-2860
[4]   Emergent stenting to treat patients with carotid artery dissection - Clinically and radiologically directed therapeutic decision making [J].
Cohen, JE ;
Leker, RR ;
Gotkine, M ;
Gomori, M ;
Ben-Hur, T .
STROKE, 2003, 34 (12) :E254-E257
[5]   Differential features of carotid and vertebral artery dissections The CADISP Study [J].
Debette, S. ;
Grond-Ginsbach, C. ;
Bodenant, M. ;
Kloss, M. ;
Engelter, S. ;
Metso, T. ;
Pezzini, A. ;
Brandt, T. ;
Caso, V. ;
Touze, E. ;
Metso, A. ;
Canaple, S. ;
Abboud, S. ;
Giacalone, G. ;
Lyrer, P. ;
del Zotto, E. ;
Giroud, M. ;
Samson, Y. ;
Dallongeville, J. ;
Tatlisumak, T. ;
Leys, D. ;
Martin, J. J. .
NEUROLOGY, 2011, 77 (12) :1174-1181
[6]   Cervical-artery dissections: predisposing factors, diagnosis, and outcome [J].
Debette, Stephanie ;
Leys, Didier .
LANCET NEUROLOGY, 2009, 8 (07) :668-678
[7]   Cervical artery dissection -: clinical features, risk factors, therapy and outcome in 126 patients [J].
Dziewas, R ;
Konrad, C ;
Dräger, B ;
Evers, S ;
Besselmann, M ;
Lüdemann, P ;
Kuhlenbäumer, G ;
Stögbauer, F ;
Ringelstein, EB .
JOURNAL OF NEUROLOGY, 2003, 250 (10) :1179-1184
[8]   Long-term follow-up after extracranial internal carotid artery dissection [J].
Engelter, ST ;
Lyrer, PA ;
Kirsch, EC ;
Steck, AJ .
EUROPEAN NEUROLOGY, 2000, 44 (04) :199-204
[9]   Antiplatelets versus anticoagulation in cervical artery dissection [J].
Engelter, Stefan T. ;
Brandt, Tobias ;
Debette, Phanie ;
Caso, Valeria ;
Lichy, Christoph ;
Pezzini, Alessandro ;
Abboud, Sherine ;
Bersano, Anna ;
Dittrich, Ralf ;
Grond-Ginsbach, Caspar ;
Hausser, Ingrid ;
Kloss, Manja ;
Grau, Armin J. ;
Tatlisumak, Turgut ;
Leys, Didier ;
Lyrer, Philippe A. .
STROKE, 2007, 38 (09) :2605-2611
[10]   Aspirin vs anticoagulation in carotid artery dissection A study of 298 patients [J].
Georgiadis, D. ;
Arnold, M. ;
von Buedingen, H. C. ;
Valko, P. ;
Sarikaya, H. ;
Rousson, V. ;
Mattle, H. P. ;
Bousser, M. G. ;
Baumgartner, R. W. .
NEUROLOGY, 2009, 72 (21) :1810-1815